Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial | Zendy

Brian Porter | Zendy; Kara B. Anthony | Zendy; Jean Shen | Zendy; Barbara Hahn | Zendy; Chris Keh | Zendy; Frank Maldarelli | Zendy; William C. Blackwelder | Zendy; H. Clifford Lane | Zendy; Joseph A. Kovacs | Zendy; Richard T. Davey | Zendy; Irini Sereti | Zendy

Open Access

Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial

Author(s) -

Brian Porter,

Kara B. Anthony,

Jean Shen,

Barbara Hahn,

Chris Keh,

Frank Maldarelli,

William C. Blackwelder,

H. Clifford Lane,

Joseph A. Kovacs,

Richard T. Davey,

Irini Sereti

Publication year - 2008

Publication title -

aids

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.195

H-Index - 216

eISSN - 1473-5571

pISSN - 0269-9370

DOI - 10.1097/qad.0b013e32831cc114

Subject(s) - medicine , confidence interval , gastroenterology , viral load , randomized controlled trial , immunology , prospective cohort study , aldesleukin , immune system , human immunodeficiency virus (hiv) , surgery , t cell

To evaluate whether interleukin (IL)-2 in patients with chronic HIV infection can maintain CD4 T cell counts during 6 months of HAART interruption.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore